Market Research Logo

Global Companion Diagnostic Market Analysis 2016 - Forecast to 2022

Global Companion Diagnostic Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Companion Diagnostics". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
  • Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping mapping the key common trends
  • Company profiling covering the financials, recent activities and the future strategies
  • Supply chain trends mapping the recent advancements
  • Strategic recommendations for the new entrants


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Companion Diagnostic Market by Technology
5.1 Introduction
5.2 Real Time PCR
5.3 Immunohistochemistry (IHC)
5.4 Gene Sequencing
5.5 Molecular Diagnostics
5.5.1 In-situ Hybridization
5.5.1.1 Chromogenic In-Situ Hybridization (CISH)
5.5.1.2 Fluorescent In-situ Hybridization (FISH)
5.6 Other Technologies
5.6.1 Cellular Immune Testing
5.6.2 Next-generation sequencing (NGS)
5.6.3 Monoclonal Antibodies (Mab)
5.6.4 Multiplex Assay
6 Companion Diagnostic Market by Application
6.1 Introduction
6.2 Colorectal Cancer
6.3 Gastric Cancer
6.4 Breast Cancer
6.5 Melanoma
6.6 Lung Cancer
6.7 Other Indications
6.7.1 Leukemia
6.7.2 Prostate
6.7.3 Infectious Disease & Neurology
6.7.4 Ovarian
7 Companion Diagnostic Market by End User
7.1 Introduction
7.2 Reference Lab
7.3 Pharmaceutical Companies
7.4 Other End User
7.4.1 Hospitals & Academic Medical Centers
7.4.2 Cro
7.4.3 Physicians
8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Novartis AG
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Myriad Genetics, Inc.
10.3 Leica Microsystems
10.4 GlaxoSmithKline plc
10.5 Abbott Laboratories, Inc.
10.6 Thermo Fisher Scientific, Inc.
10.7 Biomérieux
10.8 Becton, Dickinson and Company (BD)
10.9 Danaher Corporation
10.10 Roche (F. Hoffmann-La Roche Ltd.)
10.11 Agilent Technologies, Inc
10.12 Pfizer Inc.
10.13 Qiagen N.V.
10.14 Merck & Co., Inc.
10.15 Biogenex Laboratories
10.16 Resonance Health Ltd
10.17 Ge Healthcare
10.18 Life Technologies
10.19 Ventana Medical Systems
11 Appendix
12 Disclaimer
List of Tables
Table 1 Global Companion Diagnostic Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Companion Diagnostic Market Analysis, by Technology, 2013-2022 ($MN)
Table 3 Global Real Time PCR Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Real Time PCR Market Analysis, by Application, 2013-2022 ($MN)
Table 5 Global Real Time PCR Market Analysis, by End User, 2013-2022 ($MN)
Table 6 Global Immunohistochemistry (IHC) Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Immunohistochemistry (IHC) Market Analysis, by Application, 2013-2022 ($MN)
Table 8 Global Immunohistochemistry (IHC) Market Analysis, by End User, 2013-2022 ($MN)
Table 9 Global Gene Sequencing Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Gene Sequencing Market Analysis, by Application, 2013-2022 ($MN)
Table 11 Global Gene Sequencing Market Analysis, by End User, 2013-2022 ($MN)
Table 12 Global Molecular Diagnostics Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Molecular Diagnostics Market Analysis, by Application, 2013-2022 ($MN)
Table 14 Global Molecular Diagnostics Market Analysis, by End User, 2013-2022 ($MN)
Table 15 Global Other Technologies Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Other Technologies Market Analysis, by Application, 2013-2022 ($MN)
Table 17 Global Other Technologies Market Analysis, by End User, 2013-2022 ($MN)
Table 18 Global Companion Diagnostic Market Analysis, by Application, 2013-2022 ($MN)
Table 19 Global Colorectal Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global Colorectal Cancer Market Analysis, by Technology, 2013-2022 ($MN)
Table 21 Global Colorectal Cancer Market Analysis, by End User, 2013-2022 ($MN)
Table 22 Global Gastric Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 23 Global Gastric Cancer Market Analysis, by Technology, 2013-2022 ($MN)
Table 24 Global Gastric Cancer Market Analysis, by End User, 2013-2022 ($MN)
Table 25 Global Breast Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 26 Global Breast Cancer Market Analysis, by Technology, 2013-2022 ($MN)
Table 27 Global Breast Cancer Market Analysis, by End User, 2013-2022 ($MN)
Table 28 Global Melanoma Market Analysis, by Region, 2013-2022 ($MN)
Table 29 Global Melanoma Market Analysis, by Technology, 2013-2022 ($MN)
Table 30 Global Melanoma Market Analysis, by End User, 2013-2022 ($MN)
Table 31 Global Lung Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 32 Global Lung Cancer Market Analysis, by Technology, 2013-2022 ($MN)
Table 33 Global Lung Cancer Market Analysis, by End User, 2013-2022 ($MN)
Table 34 Global Other Indications Market Analysis, by Region, 2013-2022 ($MN)
Table 35 Global Other Indications Market Analysis, by Technology, 2013-2022 ($MN)
Table 36 Global Other Indications Market Analysis, by End User, 2013-2022 ($MN)
Table 37 Global Companion Diagnostic Market Analysis, by End User, 2013-2022 ($MN)
Table 38 Global Reference Lab Market Analysis, by Region, 2013-2022 ($MN)
Table 39 Global Reference Lab Market Analysis, by Technology, 2013-2022 ($MN)
Table 40 Global Reference Lab Market Analysis, by Application, 2013-2022 ($MN)
Table 41 Global Pharmaceutical Companies Market Analysis, by Region, 2013-2022 ($MN)
Table 42 Global Pharmaceutical Companies Market Analysis, by Technology, 2013-2022 ($MN)
Table 43 Global Pharmaceutical Companies Market Analysis, by Application, 2013-2022 ($MN)
Table 44 Global Other End User Market Analysis, by Region, 2013-2022 ($MN)
Table 45 Global Other End User Market Analysis, by Technology, 2013-2022 ($MN)
Table 46 Global Other End User Market Analysis, by Application, 2013-2022 ($MN)
Note: Regional tables are presented in the similar manner as the above

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report